<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font14">for </span>
   <span class="font14">was </span>
   <span class="font14">ACE </span>
   <span class="font14">with </span>
   <span class="font13">The </span>
   <span class="font13">AAA </span>
   <span class="font13">effect </span>
   <span class="font13">patients </span>
   <span class="font13">that </span>
   <span class="font13">were </span>
   <span class="font13">not </span>
   <span class="font12">aneurysm </span>
   <span class="font12">study </span>
   <span class="font12">{background </span>
   <span class="font12">aortic </span>
   <span class="font12">[–.– </span>
   <span class="font12">inhibitors </span>
   <span class="font12">from </span>
   <span class="font12">−.] </span>
   <span class="font12">[.–.] </span>
   <span class="font12">al. </span>
   <span class="font12">are </span>
   <span class="font11">margin </span>
   <span class="font11">wall </span>
   <span class="font11">{border-style </span>
   <span class="font11">abdominal </span>
   <span class="font11">analysis </span>
   <span class="font11">px;} </span>
   <span class="font11">ramipril </span>
   <span class="font11">this </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">PHAST </span>
   <span class="font11">cell </span>
   <span class="font11">growth </span>
   <span class="font11">This </span>
   <span class="font11">using </span>
   <span class="font11">anti-inflammatory </span>
   <span class="font11">effects </span>
   <span class="font11">expression </span>
   <span class="font11">inflammatory </span>
   <span class="font11">[–.–.] </span>
   <span class="font11">data </span>
   <span class="font11">double </span>
   <span class="font11">inhibitor </span>
   <span class="font11">activation </span>
   <span class="font11">progression </span>
   <span class="font11">blood </span>
   <span class="font11">protein </span>
   <span class="font11">these </span>
   <span class="font11">inhibition </span>
   <span class="font11">treatment </span>
   <span class="font10">Figure </span>
   <span class="font10">IL- </span>
   <span class="font10">clinical </span>
   <span class="font10">pressure </span>
   <span class="font10">reduced </span>
   <span class="font10">vascular </span>
   <span class="font10">(CD), </span>
   <span class="font10">Vasc </span>
   <span class="font10">control </span>
   <span class="font10">dilution, </span>
   <span class="font10">disease. </span>
   <span class="font10">human </span>
   <span class="font10">macrophage </span>
   <span class="font10">such </span>
   <span class="font10">trial </span>
   <span class="font10">.*) </span>
   <span class="font10">all </span>
   <span class="font10">analysis. </span>
   <span class="font10">angiotensin </span>
   <span class="font10">cells </span>
   <span class="font10">context </span>
   <span class="font10">diabetic </span>
   <span class="font10">enzyme </span>
   <span class="font10">levels </span>
   <span class="font10">multiple </span>
   <span class="font10">px; </span>
   <span class="font10">samples </span>
   <span class="font10">staining </span>
   <span class="font10">those </span>
   <span class="font10">used </span>
   <span class="font10">{font-family </span>
   <span class="font10">Cell </span>
   <span class="font10">MCP- </span>
   <span class="font10">Medical </span>
   <span class="font10">[], </span>
   <span class="font10">associated </span>
   <span class="font10">based </span>
   <span class="font10">did </span>
   <span class="font10">disease </span>
   <span class="font10">doxycycline </span>
   <span class="font10">evaluated </span>
   <span class="font10">font-size </span>
   <span class="font10">mRNA </span>
   <span class="font10">matrix </span>
   <span class="font10">may </span>
   <span class="font10">model </span>
   <span class="font10">number </span>
   <span class="font10">performed </span>
   <span class="font10">potential </span>
   <span class="font10">reduction </span>
   <span class="font10">two </span>
   <span class="font10">(clone </span>
   <span class="font10">,*) </span>
   <span class="font10">ACE-inhibitors </span>
   <span class="font10">IL-, </span>
   <span class="font10">Ramipril </span>
   <span class="font10">[]. </span>
   <span class="font10">[]–[] </span>
   <span class="font10">[–] </span>
   <span class="font10">after </span>
   <span class="font10">comprehensive </span>
   <span class="font10">diameter </span>
   <span class="font10">difference </span>
   <span class="font10">double; </span>
   <span class="font10">group </span>
   <span class="font10">has </span>
   <span class="font10">inflammation. </span>
   <span class="font10">markers </span>
   <span class="font10">observed </span>
   <span class="font10">open </span>
   <span class="font10">positive </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">sub </span>
   <span class="font10">Aneurysm </span>
   <span class="font10">Baseline </span>
   <span class="font10">N =  </span>
   <span class="font10">Results </span>
   <span class="font10">Surg:–. </span>
   <span class="font10">Vascular </span>
   <span class="font10">Yet, </span>
   <span class="font10">activity </span>
   <span class="font10">aneurysm. </span>
   <span class="font10">authors </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">cells. </span>
   <span class="font10">characteristics </span>
   <span class="font10">clear </span>
   <span class="font10">conclusion </span>
   <span class="font10">considered </span>
   <span class="font10">content </span>
   <span class="font10">controls </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">followed </span>
   <span class="font10">growth. </span>
   <span class="font10">indicate </span>
   <span class="font10">inflammation </span>
   <span class="font10">influence </span>
   <span class="font10">isotype </span>
   <span class="font10">level </span>
   <span class="font10">macrophages </span>
   <span class="font10">more </span>
   <span class="font10">obtained </span>
   <span class="font10">other </span>
   <span class="font10">patient </span>
   <span class="font10">per </span>
   <span class="font10">rabbit </span>
   <span class="font10">receptor </span>
   <span class="font10">respect </span>
   <span class="font10">result </span>
   <span class="font10">shift </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">their </span>
   <span class="font10">therapy </span>
   <span class="font10">through </span>
   <span class="font10">thus </span>
   <span class="font10">tissue </span>
   <span class="font10">van </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Figure </span>
   <span class="font10">ACE-inhibition </span>
   <span class="font10">ACE-inhibitor </span>
   <span class="font10">All </span>
   <span class="font10">Ann </span>
   <span class="font10">Aortic </span>
   <span class="font10">B-cell </span>
   <span class="font10">Cathepsin </span>
   <span class="font10">DakoCytomation), </span>
   <span class="font10">MMP- </span>
   <span class="font10">Patients </span>
   <span class="font10">TGFβ/SMAD </span>
   <span class="font10">Trial </span>
   <span class="font10">University </span>
   <span class="font10">also </span>
   <span class="font10">aneurysm: </span>
   <span class="font10">aneurysms </span>
   <span class="font10">antibody; </span>
   <span class="font10">aspects </span>
   <span class="font10">atherosclerosis. </span>
   <span class="font10">atherosclerotic </span>
   <span class="font10">available </span>
   <span class="font10">background </span>
   <span class="font10">been </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">content. </span>
   <span class="font10">courier; </span>
   <span class="font10">diagram </span>
   <span class="font10">em; </span>
   <span class="font10">factor </span>
   <span class="font10">follow </span>
   <span class="font10">included </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">its </span>
   <span class="font10">lowering </span>
   <span class="font10">medium </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">monocyte </span>
   <span class="font10">observations </span>
   <span class="font10">part </span>
   <span class="font10">patients. </span>
   <span class="font10">possible </span>
   <span class="font10">power </span>
   <span class="font10">preclinical </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">progression. </span>
   <span class="font10">pt;} </span>
   <span class="font10">receiving </span>
   <span class="font10">response </span>
   <span class="font10">role </span>
   <span class="font10">separately </span>
   <span class="font10">show </span>
   <span class="font10">staining; </span>
   <span class="font10">suppression </span>
   <span class="font10">taking </span>
   <span class="font10">test </span>
   <span class="font10">under </span>
  </p>
 </body>
</html>
